The first is the production cost of drugs.
The research and development, production and marketing of drugs all need huge funds. Drug research and development needs a lot of laboratory research and clinical trials, and a lot of manpower, material resources and financial resources. At the same time, the production of drugs requires high-end equipment and technology, and the investment of these equipment and technology is also very expensive. In addition, the production process of drugs needs to comply with various laws, regulations and quality standards, which also increases the production cost.
Second, the operating costs of medical institutions are high.
. The operating cost of medical institutions is also one of the reasons for the high drug price. Medical institutions need to pay staff salaries, medical equipment and medical supplies procurement costs, rent, utilities and other expenses, which is related to the price of drugs. Especially in large general hospitals, these costs are higher. In addition, medical institutions also need to invest huge sums of money for health and epidemic prevention and medical quality control, which is also part of the operating costs of medical institutions.
The third is the cost of drug circulation.
In the process of drug circulation, it is necessary to go through intermediaries in all links, such as wholesalers, retailers and agents. And every link needs to extract some profits from it, which eventually makes the drug price high.
The fourth is the drug pricing system.
In China, drugs are uniformly priced by the state, and the price difference of drugs is zero, but there are some defects in the drug pricing system. First of all, the price adjustment is slow, and it often takes several years or even longer to make an adjustment, which leads to the price lag.
Secondly, due to the high cost of drug research and development and production, the price of drugs is limited by national policies, which also makes it difficult for some drugs to make profits, resulting in the lack of market supply of some drugs.
Therefore, to reduce the price of drugs, we need to start from many aspects. First of all, the state should speed up the adjustment of drug prices to ensure that drug prices match production costs.
Secondly, it is necessary to optimize the operating environment of medical institutions and reduce the operating costs of medical institutions, thus reducing the price of drugs. At the same time, it is necessary to optimize the circulation of drugs and reduce the profit extraction of intermediate links.
Finally, it is necessary to improve the drug pricing system and better balance the relationship between drug price and R&D and production cost. Only through multi-party efforts can we really reduce the price of drugs and benefit more people.